Join
Live feed
·
INSIDERFilingvia Quantisnow
Krystal Biotech Inc. logo

Chief Accounting Officer Romano Kathryn converted options into 8,050 shares, covered exercise/tax liability with 3,502 shares and sold $200,700 worth of shares (750 units at $267.60), increasing direct ownership by 20% to 22,366 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KRYS (Krystal Biotech Inc.) and more on Quantisnow.